EAN Congress 2026: Best Poster Winners

Congratulations to the winners of the Best Poster Award at the 12th Congress of the European Academy of Neurology in Geneva.

Best Poster Award Winners

Winner 1: Andrea Mastrangelo
Semiquantitative neuropathologic thresholds for cerebrospinal fluid biomarker alterations in Alzheimer’s disease

Winner 2: Evelaine Louis
Sensory neuronopathy in chronic alcohol users: A retrospective bicentric cohort study

Winner 3: Giulia Bonato
Disease course in primary brain calcification: A monocentric longitudinal study from an Italian Cohort

Best Poster Award: Nominated Presentations

Choose a category to jump to that section, or browse the whole list below.

Ageing and Dementia | Autonomic nervous system diseases | Cerebrovascular diseases | Child neurology/developmental neurology | Clinical neurophysiology | Cognitive neurology/neuropsychology | Epilepsy | Headache | Infectious diseases | Motor neurone diseases | Movement disorders | MS and related disorders | Muscle and neuromuscular junction disorder | Neurocritical care | Neuroepidemiology | Neurogenetics | Neuroimaging | Neuroimaging and Neurosonology | Neuroimmunology | Neurological manifestation of systemic diseases | Neuro-oncology | Neuro-ophthalmology/ neuro-otology | Neuropathies | Neurorehabilitation | Neurorehabilitation and Neurotraumatology | Neurotoxicology/occupational neurology | Pain | Peripheral nerve disorders | Sleep-wake disorders | Spinal cord and root disorders | Treatment in MS and related disorders

---

Ageing and Dementia

Andrea Mastrangelo

EPO-0326 Semiquantitative neuropathologic thresholds for cerebrospinal fluid biomarker alterations in Alzheimer’s disease

Lucrezia Bonino

EPO-0171 | GALECTIN-3 as an emerging biomarker of neuroinflammation in Alzheimer’s disease and frontotemporal dementia

Marian Galovic

EPO-0001 | Sodium channel blockers are associated with reduced dementia risk in late-onset unexplained epilepsy

Nils Schröter

EPO-0965 | Whole-brain DTI-ALPS: A novel voxel-based biomarker for white matter dysfunction in Alzheimer’s and Parkinson’s disease

Noah J. Graves

EPO-0496 | GFPaint: A novel technique for visualizing alpha-synuclein strains across synucleinopathies

Autonomic nervous system diseases

Grace Winningham

EPO-0016 | The burden of neurogenic orthostatic hypotension across autonomic disorders: Real-world management outcomes

Cerebrovascular diseases

Ana Sánchez Asensio

EPO-0825 | Impact of endovascular treatment in patients aged ≥85 years with large vessel occlusion ischemic stroke

Francesca Gabriele

EPO-0029 | Early versus late starting of direct oral anticoagulants after breakthrough ischemic stroke: A target trial analysis from the ASPERA-R study

Kateryna Antonenko

EPO-0192 | Determinants of functional outcome in patients with intracranial atherosclerotic stenosis: Analysis of the bernese intracranial stenosis study

Mariana Costa Taveira

EPO-0357 | Validation of the DIAS³ score in cerebral venous thrombosis patients treated by decompressive surgery

Mattia Losa

EPO-0685 | Association between cortical microinfarcts and cortical superficial siderosis in cerebral amyloid angiopathy: Evidence for a double-hit mechanism?

Orionas-Vasilis Saprikis

EPO-0525 | Neuroanatomic correlates of conjugate eye deviation in left hemispheric stroke

Simran Arora

EPO-0976 | Prior stroke or transient ischaemic attack history and intensive care unit outcomes: A propensity-matched cohort study

Qi Li

EPO-0207 | Symptomatic and asymptomatic hematoma growth: Definition, prevalence and association with outcomes in intracerebral hemorrhage

Child neurology/developmental neurology

Lucas Raniolo

EPO-0042 | Speech, language, social communication, and communication assessments in Rett syndrome: A systematic review

Clinical neurophysiology

Amedeo De Grado

EPO-1027 | Towards a neurophysiological biomarker of neurotoxicity in Charcot-Marie-tooth disease

Tomasz Szczepanski

EPO-1041 | Identifying normality in historical datasets by multidimensional nerve conduction studies

Cognitive neurology/neuropsychology

Elisabeth Rounis

EPO-0552 | Core components of apraxia differentially predict disability after stroke: Evidence from principal component analysis

Filippo Cieri

EPO-0386 | Early-life multidomain engagement relates to semantic fluency and episodic learning in aging and mild cognitive impairment

José Miguel Alves

EPO-0065 | Non-motor features: Distinguishing dementia with Lewy bodies from Alzheimer’s and amyloid co-Pathology

Pol Huedo

EPO-0227 | Probiotic Lactiplantibacillus plantarum KABP051 prevents depressive-like symptoms in drosophila melanogaster and murine models of depression

Epilepsy

Cecilia Friedrichs-Maeder

EPO-0234 | A new non-invasive approach to quantify pharmacological modulation of cortical excitability

Charlotte Robitaille

EPO-0562 | Continuous versus routine EEG impact on the management of critically ill adults: Analysis of the CERTA study

Ionut-Flavius Bratu

EPO-0076 | Cumulative hippocampal seizure-related burden impairs long-term memory consolidation in focal epilepsy

Simona Lattanzi

EPO-0406 | Evaluating gender related outcomes with adjunctive cenobamate in focal-onset seizures

Headache

Andrew Blumenfeld

LB_09 | Bocunebart (anti-PACAP monoclonal antibody Lu AG09222) in adults with migraine and prior preventive treatment failures: Phase 2 program outcomes

Aliya Yakubova

EPO-0575 | Genetic associations of TRPM8 with migraine chronification

Dimos-Dimitrios Mitsikostas

EPO-0735 | People with migraine and two years treatment with anti-CGRP therapies. Second report from the prospective national registry “HERCULES”

Francescantonio Cammarota

EPO-0087 | Neurophysiological effects of ATOgepant in high-frequency episodic Migraine: the ATOM Project

Mariia Kutusheva

EPO-1022 | Assessment of cortical excitability in migraine patients using the paired-pulse transcranial magnetic stimulation technique

Pubudu Amarasena

EPO-0409 | Most bothersome non-pain symptoms in migraine and their response to CGRP monoclonal antibodies: A service evaluation

Sushmita Das

EPO-0093 | Improving diagnostic reasoning in headache disorders through an ICHD-3–based undergraduate curriculum intervention

Infectious diseases

Abdul Qavi
EPO-0095 | Inflammatory markers in tubercular meningitis and their role in predicting paradoxical reaction

Jayantee Kalita

EPO-0261 | Beta-blockers in tuberculous meningitis associated cerebral salt wasting: An open label randomized controlled trial

Motor neurone diseases

Gianmaria Senerchia

EPO-0109 | REST inhibition as a therapeutic and prognostic target in amyotrophic lateral sclerosis: From siRNA silencing to serum biomarkers

Magdalena Kuzma-Kozakiewicz

EPO-0272 | Tofersen in the treatment of SOD1 ALS – A two year experience from the Polish early Access Program

Movement disorders

Alyssa Shiramba

EPO-0768 | Efficacy and safety of magnetic resonance-guided focused ultrasound thalamotomy in essential tremor: A Systematic review and meta-analysis

Andrea Gardoni

EPO-0655 | Alterations of amygdala volume and functional connectivity in Parkinson’s disease subjects with freezing of gait

Fuad Allahverdi

EPO-0988 | Reduced hippocampus–amygdala transition area (HATA) volume in progressive multiple sclerosis: A cross-sectional MRI study

Giulia Bonato

EPO-0609 | Disease course in primary brain calcification: A monocentric longitudinal study from an Italian cohort

Giulia Visentin

EPO-0927 | Exploring genetically determined leukocyte telomere length in relation to age at onset in multiple sclerosis

Iryna Klopotovska

EPO-0753 | Effect of cognitive and motor dual-task activities on balance in patients with PPPD, FGD, and healthy controls

Jacopo Bissacco

EPO-0896 | Clinical features and brain structural correlates of blood lipid profile in idiopathic normal-pressure hydrocephalus

Konrad P. Weber

EPO-0762 | Artificial intelligence–driven identification of Parkinson’s disease using oculometrics

Louis Kälble

EPO-0122 | Spontaneous blink dynamics reveal distinct subtypes of isolated REM sleep behaviour disorder

Marko Cibula

EPO-1049 | Diagnostic sensitivity of a shortened accelerometry-only functional tremor battery

Mathilde Boussac

EPO-0452 | When personality and polygenic risk scores interact to predict impulse control disorders in Parkinson’s disease

Rita Rodrigues

EPO-0914 | Atypical late-onset PRKN-related Parkinson’s disease due to compound heterozygosity: A case report

Sahana Sathyanarayana

EPO-0595 | Olfactory impairment severity and cognitive performance in Parkinson’s disease: A 5-Year longitudinal study with baseline functional connectivity

Valentina di Foggia

EPO-0288 | Eslicarbazepine acetate shows anti-tremorgenic properties in the mouse harmaline-induced tremor model

Vito Busco

EPO-0431 | Significant elevation of serum pro-inflammatory cytokines in GBA1-associated Parkinson’s disease: Implications for immune-mediated pathogenesis


MS and related disorders

Dominika Stastna

EPO-0294 | Call for unity: 348,000 patients, six registries, one common data model for MS research

Jan Philipp Nolte

EPO-1009 | Characterization of natural killer cell aging and terminal differentiation in multiple sclerosis

Lisa Schoof

EPO-0137 | Rethinking annual MRI monitoring in ocrelizumab-treated multiple sclerosis patients: A real-world number needed to scan analysis

Maria Martinez-Serrat

EPO-0532 | Temporal dynamics of proteomic profiling in multiple sclerosis: Insights from a retrospective longitudinal study

Olli Hartiala

EPO-0465 | Microglial activation in MS brain contributes significantly to brain age gap between MS patients and controls

Stefan Gazdzinski

EPO-1001 | Functional connectivity of sensorimotor network as function of EDSS: Preliminary resting state fMRI study in patients with secondary progressive MS

Yassine Noui

EPO-0630 | Patient-reported outcomes after autologous haematopoietic stem cell transplantation compared with rituximab in multiple sclerosis

Muscle and neuromuscular junction disorder

Cécile Bez

EPO-0308 | Progression and exacerbation timing in myasthenia gravis: Real-world evidence from France (RELIEF study)

Giuseppe Di Martino

EPO-0145 | Italian real-life experience with Zilucoplan for generalized myasthenia gravis: One year of ZILU25 study

Loïc Carment

EPO-0638 | Significant correlations between ME&MGTM digital biomarkers and equivalent MG-ADL and MG-QoL15r sub-items scores

Michela Maria Corbo

EPO-0475 | Clinical and immunological features of thymoma patients with and without myasthenia gravis: A pilot study

Saiju Jacob

EPO-1053 | Efficacy and cumulative safety of cemdisiran in adults with generalised myasthenia gravis (gMG): results from the phase 3 NIMBLE trial

Neurocritical care

Anna Kristina Eigenbrodt

EPO-1061 | Stimulating consciousness recovery after acute brain injury with psilocybin and apomorphine

Neuroepidemiology

Luca Vignatelli

EPO-0807 | Risk and causes of hospitalization in persons with Parkinson’s disease or atypical parkinsonism: The ParkLink Bologna cohort

Neurogenetics

Elisabeth Van Boxstael

EPO-0156 | Predicting neurodevelopmental outcome in KCNQ2-related disorders

Luca Gallo

EPO-0646 | Cortical metabolic signatures of visuospatial and gait dysfunction in GBA1-related Parkinson’s disease

Tatiana Bremova-Ertl

EPO-0320 | Long-term (30 months) outcomes of N-Acetyl-L-Leucine in adults and children with niemann-pick disease type C

Vera Fominykh

EPO-0490 | Genetic insights into somatic symptoms and related disorders versus psychiatric phenotypes

Neuroimaging

Max Buhlan

EPO-0543 | Superior anatomical fidelity of multi-shell (MS) vs single-shell (SS) tractography for deep brain stimulation (DBS) targeting in tremor disorders

Vanessa Carvalho

EPO-0381 | Substantia nigra neuromelanin magnetic resonance imaging in LRRK2 asymptomatic carriers


Neuroimaging and Neurosonology

Francesco Garramone

EPO-0702 | Cerebrovascular reactivity in Parkinson’s disease: Acute effects of Levodopa assessed by transcranial Doppler

Neuroimmunology

Alexandra Dupic

EPO-0664 | The invisible enemy: Shedding light on antibody-negative autoimmune encephalitis

Chiara Milano

EPO-0814 | Diagnostic performance and pitfalls of a commercial assay for CASPR2 autoantibodies

Ilayda Senyuz

EPO-0507 | Uncovering novel antigenic targets of CNS-reactive autoantibodies in autoimmune neurological syndromes

Maria Sole Borioni

EPO-0342 | Long-term and patient-reported outcomes (PROs) in patients with autoimmune encephalitis: A prospective cohort study

Neurological manifestation of systemic diseases

Vincenzina Lo Re

EPO-0957 | Comprehensive cognitive and blood based biomarkers assessment in kidney transplant candidates

Neuro-oncology

Anna Luisa Di Stefano

EPO-0881 | Current pathways of rehabilitation for patients with high grade gliomas: insights from AINO, SINch and SIRN

Harmen Kuijten

EPO-0966 | Development of the AO spinal metastasis staging (SMS) referral tool: an international multidisciplinary expert panel and survey study

Neuro-ophthalmology/ neuro-otology

Alexander Heatley
EPO-0836 | The vertigo challenge: Diagnostic variability across acute referral pathways

Michele Corrado

EPO-0694 | Head circumduction paradigm as a model to stimulate the vestibulo-spinal activity

Neuropathies

Nicolas Dubuisson

EPO-0056 | GM1 neuropathies from antibody to phenotype

Panayiota Neophytou

EPO-0216 | Neuropathic pain in RFC1-related CANVAS: A systematic review and meta-analysis

Neurorehabilitation

Adrija Das
EPO-0433 | Evaluation of reticulospinal plasticity using a novel wearable (PowerBead) for post-stroke finger extension recovery

Mireia Coll i Omaña

EPO-0604 | Quantifying phenotype: A task-standardised, multimodal protocol for next-generation hyperkinetic assessment

Neurorehabilitation and Neurotraumatology

Alina Sacarescu

EPO-1010 | When copeptin and vasopressin diverge: Neuroendocrine dissociation and diffuse axonal injury in traumatic brain injury

Neurotoxicology/occupational neurology

Marta Verdeguer

EPO-0181 | Boldine and the nervous system: A case of reversible myoneuropathy


Pain

Enrico Evangelisti

EPO-0712 | Electrophysiological evidence of systemic neural hyperexcitability in trigeminal neuralgia: A nerve excitability study

Maurilio Menduni De Rossi

EPO-0861 | Immune activity in skull bone marrow and the periphery in chronic pain: A TSPO PET/MRI and LPS-stimulated cytokines study

Peripheral nerve disorders

Evelaine Louis

EPO-0870 | Sensory neuronopathy in chronic alcohol users: A retrospective bicentric cohort study

Sandra Palma

EPO-0729 | Role of magnetic resonance neurography in CIDP: Experience from a single center

Sleep-wake disorders

Daniel Sandri

EPO-0791 | Human ponto-geniculo-occipital waves: Local field potentials analysis in people with Parkinson’s disease during deep brain stimulation surgery

Eleonora Rollo

EPO-0939 | Sleep disorders in dementia with Lewy bodies: A prospective cohort study

Jari Gool

EPO-0907 | Neurometabolic differentiation of central disorders of hypersomnolence: A harmonized spectroscopy study

Spinal cord and root disorders

Samir Atweh

EPO-0850 | Clinical characteristics of toxocara canis myelitis in Lebanon: Largest single center cohort study

Treatment in MS and related disorders

Bruno Stankoff

EPO-0368 | Evolution of brain neuro-inflammation following ocrelizumab therapy in multiple sclerosis: A 2-years TSPO PET longitudinal study

Mario Risi

EPO-0787 | Effectiveness and safety of ponesimod in relapsing multiple sclerosis: Results from an Italian multicenter real-world observational study

Back to the top ↑

---

Acknowledging our EAN Congress 2026 Chairs

The EAN Congress 2026 Programme Committee acknowledges the valuable contributions of the following ePoster session chairs. Their time, expertise, and commitment to moderating the scientific discussion enhanced the quality and success of the congress. We sincerely thank each of them for their dedication.  

---